Skip to main content
Article thumbnail
Location of Repository

Speeding stroke recovery? A systematic review of amphetamine after stroke

By Nikola Sprigg and Philip M.W. Bath


Introduction: The use of drugs to enhance recovery (“rehabilitation pharmacology”) has been assessed.\ud Amphetamine can improve outcome in experimental models of stroke, and several small clinical trials have\ud assessed its use in stroke. Methods: Electronic searches were performed to identify randomised controlled\ud trials of amphetamine in stroke (ischaemic or haemorrhagic). Outcomes included functional outcome\ud (assessed as combined death or disability/dependency), safety (death) and haemodynamic measures. Data\ud were analysed as dichotomous or continuous outcomes, using odds ratios (OR), weighted or standardised\ud mean difference, (WMD or SMD) using random-effects models with 95% confidence intervals (95% CI);\ud statistical heterogeneity was assessed. Results: Eleven completed trials (n=329) were identified. Treatment\ud with amphetamine was associated with non-significant trends to increased death (OR 2.78 (95% CI, 0.75–\ud 10.23), n=329, 11 trials) and improved motor scores (WMD 3.28 (95% CI −0.48–7.04) n=257, 9 trials) but\ud had no effect on the combined outcome of death and dependency (OR 1.15 (95% CI 0.65–2.06, n=206, 5\ud trials). Amphetamine increased systolic blood pressure (WMD 9.3 mmHg, 95% CI 3.3–15.3, n=106, 3 trials)\ud and heart rate (WMD 7.6 beats per minute (bpm), 95% CI 1.8–13.4, n=106, 3 trials). Despite variations in\ud treatment regimes, outcomes and follow-up duration there was no evidence of significant heterogeneity or\ud publication bias. Conclusion: No evidence exists at present to support the use of amphetamine after stroke.\ud Despite a trend to improved motor function, doubts remain ove

Publisher: Elsevier
Year: 2009
OAI identifier:
Provided by: Nottingham ePrints

Suggested articles


  1. A double-blind placebo-controlled study of the use of amphetamine in the treatment of aphasia.
  2. Amphetamine fails to facilitate motor performance and to enhance motor recovery among stroke patients with mild arm paresis: Interim analysis and termination of a double blind, randomised, placebo-controlled trial. Restorative Neurology and Neuroscience.
  3. Amphetamine increases blood pressure and heart rate but has no effect on motor recovery or cerebral haemodynamics in sub-acute ischaemic stroke: results of a randomised controlled trial (ISRCTN 36285333). Journal of Human Hypertension.
  4. (1339). Amphetamine paired with physical therapy accelerates motor recovery after stroke. doi
  5. Amphetamine promotes recovery from sensory-motor integration deficit after thrombotic infarction of the primary somatosensory rat cortex.
  6. Amphetamine with experience promotes recovery of locomotor function after unilateral frontal cortex injury in the cat. Brain Res. doi
  7. (2008). Amphetamines for improving recovery after stroke (Cochrane Review). The Cochrane Database of Systematic Reviews.
  8. An fMRI study of the effect of amphetamine on brain activity.
  9. and experience interact to affect rate of recovery after motor cortex injury.
  10. Cardiac baroreceptor sensitivity predicts long-term outcome after acute ischemic stroke. doi
  11. Catecholaminergic Consolidation of Motor Cortex Neuroplasticity in Humans. Cerebral Cortex. doi
  12. (2001). Comparison of physical therapy and physical therapy with amphetamines in sensorimotor recovery of acute stroke patients: randomised control. J Neurol Sci.
  13. De zubicaray GI. Assessment of dynamic suceptibility contract cerebral blood flow response to amphetamine challenge: a human pharmacological magnetic resonace imaging study at 1.5 and 4T. Magnetic Resonance in Medicine. doi
  14. (1998). Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? The Lancet.
  15. Effect of dextroamphetamine on motor recovery after stroke.
  16. Effects of amphetamine and/or l-dopa and physiotherapy after stroke - a blinded randomized study. Acta Neurol Scand. doi
  17. Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with D-amphetamine therapy after neocortical infarction in rats.
  18. Evaluation of the Effect of Dextro-Amphetamin Added
  19. for the IST Collaborative Group. Blood pressure and clinical outcomes
  20. Methamphetamine Potentiates Ischemia/Reperfusion Insults after Transient Middle Cerebral Artery Ligation. doi
  21. Modifications of Practice-dependent Plasticity in Human Motor Cortex by Neuromodulators. Cerebral Cortex. doi
  22. Modulation of Use-Dependent Plasticity by D-Amphetamine. Annals of Neurology.
  23. Motor impairment and recovery in the upper limb after stroke: Behavioural and Neuroanatomical correlates. doi
  24. (2008). Motor Recovery and
  25. Motor recovery in recent stroke patients treated with amphetamine and physical therapy.
  26. Motor response to amphetamine treatment, taskspecific training, and limited motor experience in a postacute animal stroke model. Experimental Neurology. doi
  27. No benefit from D-amphetamine when added to physiotherapy after stroke: a randomised placebo-controlled study. Clinical Rehabilitation. doi
  28. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine.
  29. Pharmacological enhancement of recovery from stroke. Current Medical Literature: Stroke Review.
  30. Physiotherapy coupled with Dextroamphetamine for rehabilitation after hemiparetic stroke.
  31. Pressor Therapy in Acute Ischemic Stroke. Systematic review. doi
  32. Recruiting Subjects for Acute Stroke Trials: A Meta-Analysis.
  33. Regional cerebral blood flow response to oral amphetamine challenge in healthy volunteers.
  34. Safety of dexamphetamine in acute ischaemic strokerandomized double-blind controlled dose escalation trial.
  35. Stroke Research Priorities for the Next Decade -- A Representative View of the European Scientific Community. CerebrovascDis.
  36. Stroke Therapy Academic Industry Roundtable (STAIR). Recommendations for standards regarding preclinical neuroprotective and restorative drug development. doi
  37. The Amphetamine Enhanced Stroke Recovery (AESR)
  38. Turpie AGG, for the TAIST Investigators. Relationship between functional outcome and baseline blood pressure, pulse pressure and heart rate in acute ischaemic stroke: data from the TAIST trial.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.